Dear All,
We have been working hard to make the 4th MENA Regulatory Conference a successful event this year, yet with other countries at different stages of recovery from COVID-19 and with international travel only returning slowly, it is clear that it will be difficult to ensure the same level of participation and the usual quality of experience. Therefore, please know, it has been decided to postpone the 4th MENA Regulatory Conference to autumn of 2021.
We will be looking forward to welcoming you in 2021
Under the patronage of his Excellency Director General of Jordan Food and Drug Administration, Dr. Nizar Mhaidat; the organizers announce the 4th MENA Regulatory Conference on Bioequivalence, Biowaivers, Bioanalysis and Dissolution.
This is one of the most important events planned for this year in the region due to the presence of international, well-known, keynote speakers and the participation and support of international associations. The event will bring together regulatory and science key professionals as well pharmaceutical industry and academia to share experiences, perspectives, insights and the latest regulation and technical development.
We would like to welcome you in Jordan, a well-travelled bridge between sea and desert, east and west, a land of mesmerizing beauty and contrasts, from the Jordan Valley, fertile, ever changing, to the remote desert canyons, immense and still. Participants can explore splendid desert castles, gaze in awe at the haunting wilderness of Wadi Rum, or bathe in the restful waters of the Red Sea.
We look forward to welcoming you in Amman.